Else Marie Hagelin

  • Dept. engineer
  • +47 23073527

Publications 2022

Zolfaghari S, Kaasbøll OJ, Monsen VT, Sredic B, Hagelin EMV, Attramadal H (2022)
The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2
J Biol Chem, 299 (1), 102803
DOI 10.1016/j.jbc.2022.102803, PubMed 36529291

Publications 2021

Zolfaghari S, Kaasbøll OJ, Ahmed MS, Line FA, Hagelin EMV, Monsen VT, Attramadal H (2021)
Tissue distribution and transcriptional regulation of CCN5 in the heart after myocardial infarction
J Cell Commun Signal, 16 (3), 377-395
DOI 10.1007/s12079-021-00659-7, PubMed 34854055

Publications 2019

Wickstroem K, Hagemann UB, Kristian A, Ellingsen C, Sommer A, Ellinger-Ziegelbauer H, Wirnitzer U, Hagelin EM, Larsen A, Smeets R, Bjerke RM, Karlsson J, Ryan OB, Wengner AM, Linden L, Mumberg D, Cuthbertson AS (2019)
Preclinical Combination Studies of an FGFR2 Targeted Thorium-227 Conjugate and the ATR Inhibitor BAY 1895344
Int J Radiat Oncol Biol Phys, 105 (2), 410-422
DOI 10.1016/j.ijrobp.2019.06.2508, PubMed 31255687

Publications 2018

Kaasbøll OJ, Gadicherla AK, Wang JH, Monsen VT, Hagelin EMV, Dong MQ, Attramadal H (2018)
Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation
J Biol Chem, 293 (46), 17953-17970
DOI 10.1074/jbc.RA118.004559, PubMed 30262666

Publications 2016

Kaasbøll OJ, Moe IT, Ahmed MS, Stang E, Hagelin EM, Attramadal H (2016)
CTGF/CCN2 Postconditioning Increases Tolerance of Murine Hearts towards Ischemia-Reperfusion Injury
PLoS One, 11 (2), e0149000
DOI 10.1371/journal.pone.0149000, PubMed 26872261

Publications 2013

Gravning J, Ahmed MS, Qvigstad E, Krobert K, Edvardsen T, Moe IT, Hagelin EM, Sagave J, Valen G, Levy FO, Osnes JB, Skomedal T, Attramadal H (2013)
Connective tissue growth factor/CCN2 attenuates β-adrenergic receptor responsiveness and cardiotoxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes
Mol Pharmacol, 84 (3), 372-83
DOI 10.1124/mol.113.087312, PubMed 23778361

Lauritzen KH, Morland C, Puchades M, Holm-Hansen S, Hagelin EM, Lauritzen F, Attramadal H, Storm-Mathisen J, Gjedde A, Bergersen LH (2013)
Lactate receptor sites link neurotransmission, neurovascular coupling, and brain energy metabolism
Cereb Cortex, 24 (10), 2784-95
DOI 10.1093/cercor/bht136, PubMed 23696276

Publications 2012

Moe IT, Pham TA, Hagelin EM, Ahmed MS, Attramadal H (2012)
CCN2 exerts direct cytoprotective actions in adult cardiac myocytes by activation of the PI3-kinase/Akt/GSK-3β signaling pathway
J Cell Commun Signal, 7 (1), 31-47
DOI 10.1007/s12079-012-0183-1, PubMed 23208610

Publications 2010

Øie E, Ahmed MS, Ueland T, Sikkeland LI, Dahl CP, Hagelin EM, von Lueder T, Edvardsen T, Andreassen AK, Gullestad L, Aukrust P, Yndestad A, Vinge LE, Attramadal H (2010)
Adrenomedullin is increased in alveolar macrophages and released from the lungs into the circulation in severe heart failure
Basic Res Cardiol, 105 (1), 89-98
DOI 10.1007/s00395-009-0070-y, PubMed 19823891

Publications 2009

Halvorsen R, Jenner A, Hagelin EM, Borres MP (2009)
Phadiatop infant in the diagnosis of atopy in children with allergy-like symptoms
Int J Pediatr, 2009, 460737
DOI 10.1155/2009/460737, PubMed 20041015

Publications 2000

Sharikabad MN, Hagelin EM, Hagberg IA, Lyberg T, Brørs O (2000)
Effect of calcium on reactive oxygen species in isolated rat cardiomyocytes during hypoxia and reoxygenation
J Mol Cell Cardiol, 32 (3), 441-52
DOI 10.1006/jmcc.1999.1092, PubMed 10731443

Publications 1999

Hagelin EM (1999)
Coding data from child health records: the relationship between interrater agreement and interpretive burden
J Pediatr Nurs, 14 (5), 313-21
DOI 10.1016/S0882-5963(99)80031-1, PubMed 10554444

Publications 1996

Stokke M, Hagelin EM, Brørs O (1996)
Effects of ATP on specific [3H](+)-isradipine binding in rat ventricular cardiomyocytes
Eur J Pharmacol, 303 (1-2), 115-22
DOI 10.1016/0014-2999(96)00071-4, PubMed 8804919

Stokke M, Hagelin EM, Mende U, Brørs O (1996)
Stable guanosine 5'-triphosphate-analogues inhibit specific (+)-[3H]isradipine binding in rat hearts by a Ca(2+)-lowering, G protein-independent mechanism
Pharmacol Toxicol, 78 (1), 28-36
DOI 10.1111/j.1600-0773.1996.tb00176.x, PubMed 8685083

Stokke M, Kirkebøen KA, Naess PA, Hagelin EM, Ilebekk A, Brørs O (1996)
Equal changes in L-type calcium channel density after 60 min of ischaemia in normal and ischaemically preconditioned porcine myocardium
Acta Physiol Scand, 157 (2), 147-55
DOI 10.1046/j.1365-201X.1996.494229000.x, PubMed 8800354

Publications 1994

Stokke M, Aksnes G, Lande K, Hagelin EM, Brørs O (1994)
Density of L-type calcium channels in ischaemically preconditioned porcine heart regions
Acta Physiol Scand, 150 (4), 425-30
DOI 10.1111/j.1748-1716.1994.tb09707.x, PubMed 8036910

Publications 1992

Stokke M, Hagelin EM, Poulsson C, Brørs O (1992)
Ca2+ modulates the inhibition of (+)-[3H]isradipine binding by amiloride and quinacrine
Eur J Pharmacol, 227 (4), 379-84
DOI 10.1016/0922-4106(92)90154-n, PubMed 1332872

Stokke M, Hagelin EM, Poulsson C, Patel R, Haile Y, Brørs O (1992)
Inhibition by amiloride and quinacrine of specific [3H]nitrendipine binding to rat cardiac membranes
J Pharmacol Exp Ther, 260 (3), 1366-72
PubMed 1545399

Page visits: 4697